← All trials
NCT00760032
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 24, 2008
- Primary completion
- —
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Instituto Nacional de la Nutrición Salvador ZubiranLead sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOverall official - principal investigator
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranSponsor investigator
- Laboratorios Senosiain, S.A. de C.V.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.